Home » Marijuana & CBD

Marijuana & CBD

Featured posts

What if Marijuana Becomes a Schedule III Drug?

By Jonathan Baktari, MD, US Drug Test Centers With evolving legislation, the legalization of certain drugs continues to change. There have been a lot of question marks around THC, the psychoactive substance in marijuana. Over the years, we’ve watched as the...

Are you coming to NDASA’s 2025 Conference? Share your excitement

Let your professional contacts and industry colleagues know that you will be attending, sponsoring, training, speaking or exhibiting at NDASA's 2025 Conference & Tradeshow in Jacksonville this April by posting on social media. Attendees, exhibitors, sponsors,...

The state of drug testing across the nation

By Jonathan Baktari, MD, CEO of US Drug Test Centers The laws surrounding drug use and employment drug testing are rapidly changing, and many individuals and companies are having a hard time keeping up. The change, though, is needed: With marijuana use for both...

Podcast: Member's Memo

Updates on relevant industry news, compliance issues, regulatory changes and upcoming events.

All posts

Rescheduling of Marijuana Postponed

Rescheduling of Marijuana Postponed

This week, the Drug Enforcement Administration (DEA) administrator issued a Notice of Hearing that is expected to publish in the Federal Register on Thursday, August 29. (Click here to review the Notice of Hearing) In the document, the DEA announced that a hearing on...